Connection

Raymond Anton to Catechol O-Methyltransferase Inhibitors

Back to Details
This is a "connection" page, showing publications Raymond Anton has written about Catechol O-Methyltransferase Inhibitors.
Raymond Anton
Connection Strength
0.217
Catechol O-Methyltransferase Inhibitors
  1. Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone. Neuropsychopharmacology. 2022 10; 47(11):1953-1960.
    View in: PubMed
    Score: 0.217
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.